The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells
Open accessAbstract
Imiquimod (IMQ), a synthetic agonist to Toll-like receptor (TLR) 7, is being successfully used for the treatment of certain skin neoplasms, but the exact mechanisms by which this compound induces tumor regression are not yet understood. While treating basal cell carcinoma (BCC) patients with topical IMQ, we detected, by immunohistochemistry, sizable numbers of both myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs) within the inflammatory infiltrate. Surprisingly, peritumoral mDCs stained positive for perforin and granzyme B, whereas infiltrating pDCs expressed tumor necrosis factor–related apoptosis-inducing ligand (TRAIL). The biological relevance of this observation can be deduced from our further findings that peripheral blood–derived CD11c+ mDCs acquired antiperforin and anti–granzyme B reactivity upon TLR7/8 stimulation and could use these molecules to effectively lyse major histocompatibility complex (MHC) class Ilo cancer cell lines. The same activation protocol led pDCs to kill MHC class I–bearing Jurkat cells in a TRAIL-dependent fashion. While suggesting that mDCs and pDCs are directly involved in the IMQ-induced destruction of BCC lesions, our data also add a new facet to the functional spectrum of DCs, ascribing to them a major role not only in the initiation but also in the effector phase of the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection
Serbina, N. V., Salazar-Mather, T. P., Biron, C. A., Kuziel, W. A., & Pamer, E. G. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,175
Recognition of pathogen-associated molecular patterns by TLR family
Akira, S., & Hemmi, H. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00228-6 · Cited by 1,150
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Jarrossay, D., Napolitani, G., Colonna, M., Sallusto, F., & Lanzavecchia, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3388::aid-immu3388>3.0.co;2-q · Cited by 788
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. S., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., & Wang, R.-F. (2005) · Science · doi:10.1126/science.1113401 · Cited by 746
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K., & Yagita, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1451 · Cited by 479
Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S.-L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509736102 · Cited by 456
Fanger, N. A., Maliszewski, C. R., Schooley, K., & Griffith, T. S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1155 · Cited by 413
A novel dendritic cell subset involved in tumor immunosurveillance
Taieb, J., Chaput, N., Ménard, C., Apetoh, L., Ullrich, E., Bonmort, M., Péquignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1356 · Cited by 405
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
Chan, C. W., Crafton, E., Fan, H.-N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., et al. (2006) · Nature Medicine · doi:10.1038/nm1352 · Cited by 399
Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S., & Nagai, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3678 · Cited by 377
Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/β
Sato, K., Hida, S., Takayanagi, H., Yokochi, T., Kayagaki, N., Takeda, K., Yagita, H., Okumura, K., Tanaka, N., Taniguchi, T., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3138::aid-immu3138>3.0.co;2-b · Cited by 271
Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod
Schon, M., Bong, A. B., Drewniok, C., Herz, J., Geilen, C. C., Reifenberger, J., Benninghoff, B., Slade, H. B., Gollnick, H., & Schon, M. P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg016 · Cited by 258
Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells
Chaperot, L., Blum, A., Manches, O., Lui, G., Angel, J., Molens, J.-P., & Plumas, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.248 · Cited by 256
Rissoan, M.-C., Duhen, T., Bridon, J.-M., Bendriss-Vermare, N., Péronne, C., Vis, B. D. S., Brière, F., & Bates, E. E. M. (2002) · Blood · doi:10.1182/blood-2002-02-0638 · Cited by 245
Mechanisms of Interferon-alpha induced apoptosis in malignant cells
Thyrell, L., Erickson, S., Zhivotovsky, B., Pokrovskaja, K., Sangfelt, O., Castro, J., Einhorn, S., & Grandér, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205179 · Cited by 239
Palamara, F., Meindl, S., Holcmann, M., Lührs, P., Stingl, G., & Sibilia, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3051 · Cited by 201
Self-citationUrosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., & Gilliet, M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji207 · Cited by 182
Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine.
Sidky, Y. A., Borden, E. C., Weeks, C. E., et al. (1992) · PubMed · Cited by 169
Schön, M. P., Schön, M., & Klotz, K.-N. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700286 · Cited by 164
Korman, N., Moy, R., Ling, M., Matheson, R., Smith, S., McKane, S., & Lee, J. H. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.4.467 · Cited by 164
Lu, G., Janjic, B. M., Janjic, J. M., Whiteside, T. L., Storkus, W. J., & Vujanović, N. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1831 · Cited by 140
Recruitment of dendritic cells in oral lichen planus
Santoro, A., Majorana, A., Roversi, L., Gentili, F., Marrelli, S., Vermi, W., Bardellini, E., Sapelli, P., & Facchetti, F. (2005) · The Journal of Pathology · doi:10.1002/path.1699 · Cited by 119
Microencapsulated iNOS‐expressing cells cause tumor suppression in mice
Xu, W., Liu, L., & Charles, I. G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0590fje · Cited by 113
Blomberg, K. R., Hautala, R., Lövgren, J., Mukkala, V.-M., Lindqvist, C., & Åkerman, K. E. O. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00063-4 · Cited by 110
Janjic, B. M., Lu, G., Pimenov, A. A., Whiteside, T. L., Storkus, W. J., & Vujanović, N. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1823 · Cited by 100
Schmitz, M., Zhao, S., Deuse, Y., Schäkel, K., Wehner, R., Wöhner, H., Hölig, K., Wienforth, F., Kießling, A., Bornhäuser, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4127 · Cited by 88
Theos, A. U., Cummins, R. E., Silverberg, N. B., & Paller, A. S. (2004) · PubMed · Cited by 87
Imiquimod as an antiangiogenic agent.
Li, V. W., Li, W. W., Talcott, K. E., & Zhai, A. W. (2005) · PubMed · Cited by 85
Gollnick, H. P. M., Barona, C. G., Frank, R. G. J., Ruzicka, T., Megahed, M., Tebbs, V. M., Owens, M., & Stampone, P. A. (2005) · PubMed · Cited by 75
PI‐3K/Akt and NF‐κB/IκBα pathways are activated in Jurkat T cells in response to TRAIL treatment
Zauli, G., Sancilio, S., Cataldi, A., Sabatini, N., Bosco, D., & Pietro, R. D. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20202 · Cited by 71
Vanderheyde, N., Aksoy, E., Amraoui, Z., Vandenabeele, P., Goldman, M., & Willems, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3565 · Cited by 67
Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12-Week Open-Label Trial
Peris, K., Campione, E., Micantonio, T., Marulli, G. C., Fargnoli, M. C., & Chimenti, S. (2006) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31081 · Cited by 66
Trinité, B., Chauvin, C., Pêche, H., Voisine, C., Heslan, M., & Josien, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2408 · Cited by 63
Yawalkar, N., Hunger, R. E., Buri, C., Schmid, S., Egli, F., Brand, C. U., Mueller, C., Pichler, W. J., & Braathen, L. R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64027-8 · Cited by 54
Stary, G., Bangert, C., Stingl, G., & Kopp, T. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000088865 · Cited by 50
Self-citationSmith, K., Hamza, S. H., & Skelton, H. G. (2004) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2004.01593.x · Cited by 45
Mocellin, S., Provenzano, M., Lise, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11369 · Cited by 26
PHOTODYNAMIC THERAPY AND IMIQUIMOD IMMUNOTHERAPY FOR BASAL CELL CARCINOMAS
Nikkels, A., Piérard-Franchimont, C., Nikkels‐Tassoudji, N., Bourguignon, R., & Pierard, G. (2005) · Acta Clinica Belgica · doi:10.1179/acb.2005.039 · Cited by 21
Cited by
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Intratumoural administration and tumour tissue targeting of cancer immunotherapies
Melero, I., Castanon, E., Alvarez, M., Champiat, S., & Marabelle, A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00507-y · Cited by 493
Sisirak, V., Faget, J., Gobert, M., Goutagny, N., Vey, N., Treilleux, I., Renaudineau, S., Poyet, G., Labidi-Galy, S. I., Goddard-Leon, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3468 · Cited by 345
The Yin and Yang of Toll-like receptors in cancer
Pradere, J.-P., Dapito, D. H., & Schwabe, R. F. (2014) · Oncogene · doi:10.1038/onc.2013.302 · Cited by 331
Metadata
- Authors
- Stary, G., Bangert, C., Tauber, M., Strohal, R., Kopp, T., & Stingl, G.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-05-29
- Volume
- 204
- Issue
- 6
- Pages
- 1441-1451
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2067575233
- Cited by
- 363
- References
- 47
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.